0 Ask Beta Account

Too Soon to Adopt Progesterone for the Prevention of Preterm Delivery

Paul J Meis

  • Atrium Health Wake Forest Baptist ROR
Source

Abstract

No abstract available for this article.

Topics

Pregnancy > Preterm Birth > Progesterone PreventionReproductive Endocrinology > Progesterone > Preterm DeliveryEthics/Philosophy > Clinical Practice > Premature Adoption of Interventions
progesterone prevention preterm delivery evidence, Meis progesterone preterm birth clinical adoption, 17-alpha hydroxyprogesterone caproate preterm labor prevention, progesterone supplementation recurrent preterm birth, preterm delivery prevention hormonal therapy evidence review, premature birth progesterone treatment controversy, progesterone cervical length preterm birth prevention, clinical practice adoption progesterone preterm delivery, progestogen therapy prevention spontaneous preterm birth debate, preterm labor pharmacologic prevention evidence gap

Cite this article

Meis, P. J., & Berstein, P. S. (2003). *Too Soon to Adopt Progesterone for the Prevention of Preterm Delivery*.

Related articles

ACOG Committee Opinion. Use of progesterone to reduce preterm birth
ACOG, 2003 Obstetrics and Gynecology

Preterm birth affects 12% of all births in the United States. Recent studies support the hypothesis that progesterone supplementation reduces preterm birth in a select group of women (ie, those with a...

Pregnancy > Preterm Birth > Progesterone PreventionReproductive Endocrinology > Progesterone > Pregnancy ApplicationsGeneral OB/GYN > Clinical Guidelines > ACOG Recommendations

Progestogen administration in pregnancy may prevent preterm delivery
Keirse MJ, 1990 British Journal of Obstetrics and Gynaecology

Two recently published meta-analyses of controlled trials of a wide variety of progestational agents, used in pregnancy (Daya 1989; Goldstein et al. 1989), prompted this third meta-analysis of placebo...

Pregnancy > Preterm Birth > Progesterone PreventionPregnancy > Pharmacotherapy > Progestogen SupplementationResearch Methodology > Meta-analysis > Controlled Trials

Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor
Johnson JW et al., 1975 The New England Journal of Medicine

We conducted a double-blind study to determine the efficacy of 17alpha-hydroxyprogesterone caproate in preventing premature delivery in 43 high-risk patients. Premature delivery did not occur in 18 pa...

Pregnancy > Preterm Birth > Progesterone PreventionReproductive Endocrinology > Progesterone > 17-OHPC TherapyResearch Methodology > Randomized Controlled Trials > Double-Blind Studies